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Abstract
Adenovirus is a nonenveloped, double-stranded DNA virus that contains a 36 Kbp genome. The
E4 ORF3 region of its genome consists of an E4 11k protein that can reorganize host cell
components by relocalizing cellular proteins. One such cellular component is the cytoplasmic
processing body, which consists of proteins involved in translational repression of mRNA and
mRNA degradation. During an adenovirus infection, processing body proteins Ddx6 and Pat1b
have been shown to colocalize and form aggresomes. Aggresomes induced by E4 11k are
specific to the adenovirus serotype 5 (Ad 5). In this study, cytoplasmic Pat1b foci were observed
and quantified to determine E4 11k’s effect on Pat1b during an infection. Our data reveals that
Ad 5 E4 11k is necessary and sufficient for increasing Pat1b foci in Ad 5-infected cells. To
determine whether this increase in Pat1b foci is serotype-specific, we also studied the
localization pattern of Pat1b in Ad 9 and Ad 12 E1-replacement viruses. There was a significant
increase in Pat1b foci in Ad 5-infected cells compared to mock and the other two serotypes
suggesting that rearrangement of Pat1b is serotype-specific. Additional studies were done to
determine the effect of p-body rearrangement by E4 11k on late gene expression, but the results
are currently inconclusive. Altogether, our data contributes to the understanding of how viruses
can disrupt p-body proteins during an infection.

1

Introduction
Human adenoviruses (HAdVs) are ubiquitous in humans. Depending on their
surrounding environmental conditions, these viruses can survive between seven and three months
outside of their host (Kramer et al. 2006). HAdVs belong to the genus Mastadenovirus in the
Adenoviridae family. These viruses are further classified into seven distinct species (HAdV-A to
HAdV-G) and contain over 67 serotypes. Among the 67 serotypes are 70 different viral
genotypes. Human adenoviruses serotypes 52-68 are a result of interspecies recombination
between the preexisting 51 serotypes. Recombination of this virus can potentially lead to
increased viral fitness, enhanced virulence, and altered host cell tropism. Adenoviruses can cause
an array of medical conditions associated with respiratory and gastrointestinal symptoms or a
mixture of both (Cook and Radke 2017).
Human adenoviruses are usually transmitted through aerosolized droplets (respiratory
infections) or through the fecal-oral route (gastrointestinal infections). Different subgroups tend
to be associated with certain clinical conditions. Subgroups (A, B type 1 and 2, C, D, F and G)
can cause gastrointestinal infections. Respiratory infections are caused by subgroups (A, B type
1 and 2, C and E). Subgroups (B type 1, D and E) can result in keratoconjunctivitis, and
subgroups (A, B type 1 and 2, and C) are responsible for urinary tract infections (Ghebremedhin
2014). Not many people with HAdVs will develop severe illnesses. Most severe HAdV
infections occur in immunosuppressed adults and young children; however, it is possible for
individuals with no preexisting risk factors to become severely infected (Munoz et al. 1998).
Currently, there are no drugs approved to specifically treat Adenovirus (Ad) infections;
however, Cidofovir, an antiviral drug, has clinically been used in stem cell transplant patients
when Ad DNA has been detected inside of a patient. One of Cidofovir`s functions is that it
terminates synthesis of Ad DNA, but a major concern regarding Cidofovir`s use is that it can
2

lead to kidney toxicity (Wold and Toth 2013). Another important issue is that antibodies that are
produced to target adenoviruses are serotype-specific. Since not all of the serotypes for
adenoviral infections have been studied, this presents a challenge for creating vaccines for the
general public. There is a live, oral enteric-coated vaccine that is available to military recruits to
prevent acute respiratory diseases. HAdV species B consists of multiple serotypes that are
associated with acute respiratory diseases. HAdV species B serotypes 3 and 7 are the most
common adenovirus linked to respiratory outbreaks in the US military resulting in approximately
80% of respiratory diseases among military recruits. These vaccines are used to treat Ad 4 and
Ad 7 serotypes (Chen and Tian 2018).
Advances in molecular techniques have re-established interest in adenoviral biology. As a
result, adenovirus serotype 5 (Ad 5) is well characterized. Modified versions of Ad 5 displays
promising use for future vaccination purposes and gene therapy. Additionally, adenoviral
biology has expanded our knowledge of cellular and molecular biology. For example, mRNA
splicing was first discovered in adenovirus serotype 2 (Ad 2) and contributed to our
understanding of mRNA splicing. Research on protein-protein interactions during an Ad 5
infection has also led to the discovery of multiple transcription factors (Berget et al. 1977).
Because of the vital role Ad 5 has in molecular and cellular biology, understanding the life cycle
of Ad 5 during an infection can be beneficial.
The life cycle of the adenovirus is generally categorized into two stages. This
classification is based on whether proteins are being expressed before or after viral DNA
replication. Early proteins (E1B, E2, E3, and E4) are under the control of the E1A protein. Early
proteins can target and form complexes with key cellular components. As a result, cellular
activities are manipulated to produce an environment favorable for viral DNA replication, to
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inhibit immune responses, apoptotic pathways and promote viral gene expression. The Ad
genome also consists of a major late promoter (MLP) (Figure 1) that directs the synthesis of a
late pre-mRNA. The pre-mRNA undergoes alternative splicing to produce five late mRNAs (L1L5) (Figure 1). Late transcriptional units encode structural proteins that are responsible for virion
assembly and encapsidation (Parks et al. 2005).

Figure 1: Adenovirus transcriptional map (Vetrini and Ng 2010).

In this study, we focused on the early region 4, which encodes an E4 11k protein and E4
34k protein (products of E4 ORF3 and E4 ORF6, respectively). The E4 region of the early genes
is involved in DNA replication, shutoff of cellular protein synthesis, and the production of late
viral proteins (Bridge and Ketner 1990). Mutations in the E4 region, specifically the E4 11k and
E4 34k proteins, affect viral replication and gene expression. The E4 11k protein can influence
viral replication of the Ad virus by disrupting cellular antiviral response systems and has
demonstrated that it can relocalize processing body (P-body) proteins; Lsm1, and Ddx6 to
aggresomes (Greer et al. 2011). Processing bodies are suggested to be sites for mRNA
4

degradation. During an adenovirus infection, multiple p-body proteins, including Lsm1 and
Ddx6, are relocalized to juxtanuclear aggregates, called aggresomes. Aggresomes are aggregates
of misfolded proteins and are believed to be degradation sites for proteins that are not
functioning properly (Greer et al. 2011).

Adenovirus Structure and Gene Expression
Human adenoviruses (HAdVs) are double-stranded DNA viruses that range from 65nm
to 90 nm in diameter. They consist of an inner core, which contains six proteins: 23k maturation
protease, terminal protein, V, VII, Mu, and IVa2 (Figure 2). These proteins are bundled with the
viral DNA. The core is enclosed by an icosahedral capsid that consists of major proteins and
minor proteins: IIIa, VI, VIII and IX (Figure 2). Protein VI is located below the penton base,
which allows it to interact with protein V (Vellinga et al. 2005).
Hexon (protein II), fiber (protein IV) and penton base (protein III) are the major capsid
proteins (Figure 2). The hexon capsid consists of 720 hexon monomers that form 240 hexon
homotrimers, which gives the capsid its icosahedral shape. Protein II has a hexagonal shape that
allows for optimal packaging of viral DNA. The penton protein constructs 12 penton base
complexes on the 12 vertices located on the capsid. The elongated fiber protein protrudes from
each penton base complex and initiates adenovirus infections by attaching to cellular receptors,
such as the coxsackie and adenovirus receptor (CAR) or membrane cofactor protein (MCP)
(Vellinga et al. 2005).
Once the fiber and penton base proteins bind to the host cell receptors, integrin-mediated
endocytosis occurs. Protein VI then engages in the nuclear transportation of the Ad genome by
prompting pH-independent disruptions of endosomes. Protein VI then aids the virion particles in
the departure from endosomal compartments. As a result, endosome lysis occurs and protein VI
5

Figure 2: Structure of the adenovirus core and capsid (Russell 2000).

is able to enter into the cytoplasm (Vellinga et al. 2005). After protein VI has allowed for the
virus content to be released from endosomes, virus particles are then transported to the nucleus
on microtubules by dynein motor proteins. It is taken to the microtubule organization center and
then interacts with the nucleoporin NUP214/CAN cytoplasmic filament. During its import to the
nucleus, viral DNA is coated with VII protein. Nuclear import of the Ad genome is usually a
result of nuclear localization sequence (NLS)-associated proteins binding to nucleic acids
(Johnson et al. 2004). Both protein VI and protein VII have NLSs that transport the virus from
the cytoplasm to the nucleus. Protein VII’s NLS binds to importin beta via the adapter importin
alpha or independently. This then allows for the protein VII-DNA complex to enter the nuclear
pore complex (NPC). Once protein VII and the viral DNA have entered the nucleus, they
continue to bind and remain in the nucleus until the onset of viral DNA replication. E1A
becomes the first protein expressed and initiates transcription of other viral genes (E1B, E2, E3
and E4). E1A’s ability to associate with DNA is dependent on its interaction with VII, which is
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suggested to be the initial step in stimulating transcription of other early genes. (Johnson et al.
2004). Early proteins have functions in manipulating host cell machinery to produce
environments favorable for viral replication. After approximately 12 hours post infection (hpi),
viral DNA replication occurs and late viral genes are expressed.
The late proteins (L1-L5) (Figure 1) are responsible for forming the capsid and viral
assembly and maturation (Russell 2000). After Ad DNA replication, the IX and IVa2 proteins
become highly expressed and the major late promoter (MLP) becomes fully functional for
transcription. Late viral messenger RNAs are exported from the nucleus to the cytoplasm via the
E1B 55k and E4 ORF6 complex. The IVa2 and L4 33k proteins bind to the MLP and stimulate
transcription (Ali et al. 2007). The L4-100k protein promotes viral mRNA translation by
eliminating the cap-dependent translational pathways and suppressing cellular mRNA
translational activity (Koyuncu and Dobner 2009). Efficient translation of viral RNAs requires
the L4 100k protein. In addition, L4 100k and L4 33k are involved in capsid assembly (Koyuncu
and Dobner 2009). When the L4 33k protein is mutated, it impairs the genome packaging
process by producing empty capsids (Wu et al. 2013). This means that the L4 33k protein is
important for encapsidation of the Ad viral genome. Once a sufficient number of virions are
produced, lysis of the cell occurs.

Early Adenoviral Proteins
The human adenovirus genome encodes approximately 40 proteins, which are
categorized into two major stages. Classification of Ad transcriptional units is dependent on
whether a protein is expressed before DNA replication (early) or after DNA replication (late).
Both early and late gene products have functions in transcriptional activation and translation.
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E1A is sufficient in disrupting the S-phase of the cell cycle to ensure that the virus can regulate
the host’s cellular activities and has access to cellular DNA precursors for viral replication (Liu
et al. 2021). E1A regulates the expression of other early genes: E1B, E2, E3 and E4 (Figure 2),
and numerous cellular genes (Berk 1986). Early transcriptional units (E1-E4) consist of proteins
whose primary functions are manipulating the host cells to produce environments favorable for
viral replication, initiating expression of Ad genes and directly participating in Ad DNA
replication.
The two most abundant proteins transcribed from E1A are the 12S and 13S protein. Both
proteins have roles in transcription of early viral products and modulating host cell gene
expression and proliferation. The 13S protein also interacts with the tumor suppressor protein,
p53, and can induce apoptosis independently of p53 (Putzer et al. 2000). The E1A 12S protein is
an oncoprotein involved in tumorigenesis by rescuing cells from apoptosis and senescence
(Gopalakrishnan et al. 1997) by stabilizing the p53 protein.
In Ad 12-infected cells, expression of E1A has shown there is an increase in
tumorigenicity (Eager et al. 1986) and a decrease in the major histocompatibility complex
(MHC) class I expression. The major histocompatibility complex is a large locus that contains
genes that code for multiple cell surface proteins crucial for recognizing foreign substances. This
complex binds to foreign peptides and arranges them on the cell surface to be recognized by T
cells.
After E1A is expressed, it activates transcription of E1B, E2, E3 and E4. The E3 region
consists of six known proteins. The gp 19k protein binds to the Class I antigens of the major
histocompatibility complex (MHC) and down-regulates Class I antigens by blocking
glycosylation. This prevents Class I antigens from transporting to the surface of the cell. It has
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been demonstrated that deletion of the gp 19k protein increases lymphocytes and macrophage
inflammatory response (Ginsberg et al. 1989)
Two other E3 proteins, E3 4.7k and E3 10.4k, prevent apoptosis mediated by the tumor
necrosis factors (TNF). The E3 10.4k and E3 14.5k can also control cellular signaling pathways
by down-regulating the EGF receptor (Wold and Gooding 1991). In addition, the E3 14.5k can
re-establish cell survival by inhibiting apoptotic pathways (Russell 2000). E3 11.6k is more
abundant during the late stages of Ad infection and mediates the release of Ad progeny through
apoptosis. Ad viruses that lack the E3 11.6k protein can still replicate, but viral progeny is
released at slower rates (Tollefson et al. 1996).
The E1B region codes for the E1B 19k and E1B 55k proteins. Both are known to inhibit
p53-dependent induction of apoptosis. The E1B 19k protein inhibits apoptosis mediated by the
E1A 13S and p53 proteins. E1B 19k inhibits p53 functions by preventing mitochondrial pore
formation (Cuconati and White 2002). On the other hand, E1B 55k appears to cooperate with
E1A 12S and p53 by directly binding to p53 to alleviate repression of transcriptional activation
by p53 (Kannabiran et al. 1999). The E1B 55k protein can influence the activity of p53 and
affects late viral mRNA transcription (Russell 2000).
The E4 gene produces 18 different messenger RNAs. Each mRNA encodes one of seven
distinct polypeptides ORF1-ORF3, ORF3/4, ORF4, ORF6 and ORF6/7 (Tauber and Dobner
2001). E4 gene products are involved in the shutoff of cellular protein synthesis, regulating
apoptosis, the production of progeny virions, prevention of concatenation of viral genomes, viral
mRNA splicing and transportation (Greer et al. 2011). In the late phase of Ad infection, the
ORF1 mRNA causes cytoplasmic accumulation suggesting that ORF1 contributes to cell lysis
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(Dix and Leppard 1993). The E4 ORF1 region has been observed interacting with cellular factors
and acting as a scaffolding protein in cell signaling (Fanning and Anderson 1999).
Currently, there are no known functions of the E4 ORF2 protein. The E4 ORF3 and E4
OR6 proteins work independently of each other, but they have some redundant functions. They
are able to amplify late viral gene expression by stabilizing late mRNAs (reviewed in Imperiale
et al. 1995), and stimulating viral DNA synthesis (Medghalchi et al. 1997). In addition, E4 ORF3
and E4 ORF6 proteins inhibit the double-stranded DNA (dsDNA) break repair (DBR) system by
binding to the DNA-dependent protein kinase (DNA PK) (Boyer et al. 1999). It has also been
revealed that the E4 ORF3 region binds to E1B 55k and induces small ubiquitin modifiers
(SUMO) proteins. These proteins regulate the localization of proteins and the DNA response
system. The SUMO2/3 proteins are relocalized to viral replication centers during Ad infections
(Higginbotham and O’Shea 2015).
The E1B 55k and E4 34k complex leads to the degradation of the Mre11-Rad50-Nbs1
protein complex (MRN) (Stracker et al. 2002), which is crucial for detecting double-stranded
DNA breaks. E4 11k also inhibits the double-stranded repair system by binding to the DNAdependent protein kinase (DNA PK) (Boyer et al. 1999). In the absence of E1B 55k or E4 34k,
E4 11k has demonstrated that it is essential for viral replication (Evans and Hearing 2005). The
E1B 55k-E4 34k complex and E4 11k protein work independently of one another simultaneously
to prevent viral concatenation during an Ad infection (Stracker et al. 2002). E1B 55k and E4 11k
also function in shutting off cellular protein synthesis at late stages (Shepard and Ornelles 2004).
One mechanism E4 11k may use to shut off cellular protein synthesis is by disrupting
processing bodies (p-bodies). E4 11k, specifically adenovirus serotype 5 (Ad 5), is known to
target multiple p-body proteins, such as Lsm1 and Ddx6, into aggresomes. Other serotypes at
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least relocalize Lsm1 and Ddx6 to various distinct cytoplasmic structures but have not been
found to relocalize them to aggresomes (Greer et al. 2011). Relocalization of these proteins may
allow Ad viruses to effectively replicate and produce virions.

Processing Bodies
Messenger ribonucleoprotein (mRNP) granules are cytoplasmic structures that regulate
gene expression within cells. There are two types of RNA granules conserved in eukaryotic cells:
stress granules (SGs) and processing bodies (p-bodies). Stress granules form under cellular stress
and contain multiple translational initiating factors. While p-bodies form in response to stimuli
that affect mRNA translation and contain protein involved in mRNA suppression and
degradation. Both of these RNA granules are known to be associated with mRNA storage and
decay (Reineke and Lloyd 2013) and have demonstrated their role in antiviral responses by
remodeling of cellular mRNP structures. P-bodies and stress granules interact with each other
during and after cellular stress. During the recovery period, mRNA stored in SGs and p-bodies
can be recycled and returned to polysomes for translation. In contrast, other mRNA may be
directed to p-bodies for degradation. Disruption of polysomes have shown to promote the
formation of p-bodies while stabilization of polysomes lead to p-body degradation (Kedersha et
al. 2000).
P-bodies are a network of multiple protein-protein and protein-RNA interactions that are
involved in decapping and deadenylation (Sheth and Parker 2003). Among those proteins are
translational factors, mRNA decapping enzymes (Dcp1 and Dcp2), decapping activators (Pat1b
and Ddx6), deadenylation factor and exonucleases (Xrn1), which degrades mRNA after
decapping. Inhibition of decapping activities result in increase in p-body size and abundance
while blocking deadenylation resulted in a decrease in p-body abundance. In addition to mRNA
11

processing proteins, microRNA(miRNAs) have also been shown to localize to p-bodies.
miRNAs are small, noncoding RNAs involved in gene silencing. miRNAs have been
demonstrated to bind with the RNA-induced silencing complexes (RISCs). It is suggested that
transportation of miRNAs and RISC complexes to p-bodies is crucial for miRNA-mediated gene
silencing (Jakymiw et al. 2005).

Ddx6 and P-bodies
Two p-body proteins Ddx6 and Pat1b have shown that they are essential for the
formation of p-bodies.The protein Ddx6 (also known as RCK and p54) is a member of the
DEAD-box helicase family, and it is conserved among eukaryotes (Yu et al. 2011). Homologs of
Ddx6 have multiple functions involved in mRNA metabolism processes, which gives them an
important role in regulating post-transcriptional gene expression. The Ddx6 protein is crucial for
gene silencing of several pathways. Ddx6 has functions in assembly of the decapping complex
(Nissan et al. 2010) and activation of Dcp2 (Fischer and Weis 2002). When decapping enzymes
are not available, Ddx6 is sufficient in silencing protein expression via translational suppression
(Ostarek et al. 2014).
In addition, Ddx6 is able to control various post-transcriptional activities by interacting
with the miRNA-induced silencing complex (miRISC). Two of the RISC components (Ago1 and
Ago2) localize to p-bodies and directly interact with Ddx6. The absence of Ddx6 leads to the
dispersal of Ago2, p-body dissociation, and the decrease of miRISC- mediated repression
(Ostarek et al. 2014). These interactions are suggested to be mediated by binding of Ddx6 and
Pat1b (Ozgur and Stoeklin 2013).
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Pat1b and P-bodies
Pat1b and Ddx6 are both important for the formation of p-bodies, and the absence of one
or both of these proteins result in reduced p-body formation (Ozgur and Stoeklin 2013). Pat1
proteins are conserved in eukaryotes and have evolved into two proteins (Pat1a and Pat1b). It is
suggested that Pat1a is expressed in maternally expressed germline cells and functions as a
translational repressor, whereas Pat1b is expressed in somatic cells and have functions involved
in mRNA decay (Marnef et al. 2012). Pat1b is a scaffolding protein that interacts with both
mRNA and proteins involved in translational repression. Pat1b has multiple binding sites that are
protein specific for protein decapping and deadenylation factors, which indicates that Pat1b
proteins have functions throughout the different stages of translational repression and mRNA
decapping (Pilkington and Parker 2008). The Pat1b N-terminal region has been reported to bind
Caf1 (CCR4-Not deadenylation complex subunit) while its C-terminal domain binds to
decapping proteins (Marnef et al. 2012). Pat1 interacts with Lsm1-7 through the N-terminal edge
of its C-terminal end. Pat1b’s interaction with Lsm1 is vital for the Pat1-Lsm1-7 complex to
mediate translational repression (Garre et al.2018).
The Lsm1-7-Pat1 complex interacts with the 3' end of messenger RNAs to promote the
decay of mRNAs. The Lsm1-7-Pat1 complex has revealed that it has some involvement in the
life cycle of positive-stranded RNA viruses by promoting viral translation and recruitment to
viral replication complexes (Jungfleisch et al. 2015). It has also been demonstrated that Pat1
interacts with at least eight helical leucine rich motifs on the C-terminal end of yeast decapping
enzyme Dcp2. This in return could allow Dcp2 the ability to recruit multiple Lsm1-7-Pat1
complexes that contain mRNA ready for degradation (Charenton et al. 2017).
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In eukaryotic cells, Pat1b has demonstrated that it is crucial for the formation of p-bodies
and control of post-transcriptional gene expression. The number of p-bodies in multiple cell
types have shown to increase when exogenous Pat1b is overexpressed (Ozgur et al. 2010), and
knockdown of Pat1b led to a decrease in p-bodies (Ozgur and Stoeklin 2013).

E4 11k and Ddx6 Aggresomes
E4 11k is able to rearrange nuclear and cytoplasmic structures, such as PML nuclear
bodies and p-bodies, by relocalizing specific host cell proteins. E4 11k shows that it interacts
with Ddx6 and relocalizes it to aggresomes. In Ad 5-infected cells, p-bodies containing Ddx6
decreases, which may be a consequence of E4 11k relocalizing Ddx6 to aggresomes. During a
wild type Ad 5 infection, E4 11k-expressing viruses have been shown to co-precipitate with
Ddx6 and colocalize in aggresomes with Ddx6 (Greer et al. 2011). Moderate reduction of Ddx6
in p-bodies, and its relocalization to aggresomes may be important for E4 11k to carry out its
functions. Aggresomes are cytoplasmic bodies that contain aggregates of misfolded proteins, and
they are usually observed in cells that are stressed by chemical and physical factors such as heat
shock, chemical treatments and viral infections (Garcia-Mata et al. 2002). In some cases,
proteins are able to form aggresomes when chemical stressors are present. This is the case for
Lsm-1 and Ge-1 when cells undergo cadmium treatment, however, Ddx6 remains unaffected.
This suggests that Ddx6 relocalizing to aggresomes is specifically due to its interaction with E4
11k (Greer et al. 2011).
Greer et al. observed whether E4 11k’s ability to form aggresomes was serotypespecific (2011). The distribution of E4 11k and Ddx6 was observed in Ad 3, Ad 4, Ad 5, Ad 9
and Ad 12, which represents five of the seven human adenovirus subgroups. It was determined
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that E4 11k’s ability to form aggresomes was specific to E4 11k`s ability to interact with both
RecA-like domains on Ddx6. Further studies need to be conducted to find the physical binding
sites of Ddx6 on E4 11k; however, single amino acid substitutions (N82A, L103A) and a double
amino acid substitution (D105A/L106A) on E4 11k prevents it from rearranging key cellular
proteins, such as PML proteins, which results in knockdown of many of its functions. These
amino acid substitutions also prevent E4 11k and Ddx6 binding (Greer et al. 2011). As a result,
E4 11k is not able to form aggresomes with Ddx6, which is proposed to play an important role in
viral growth. When E4 11k-induced aggresomes are present, it appears that relocalization of
Ddx6 to aggresomes reduces the number of p-bodies containing Ddx6 (Greer et al. 2011). Some
p-bodies containing Ddx6 are still observed, indicating that absolute removal of Ddx6 is not
essential for E4 11k’s functions (Greer et al. 2011).

E411k and Pat1b
More recently, Pat1b has been observed during an Ad 5 infection, and it appears to be
relocalized as well. Ddx6 and Pat1b have shown that they can colocalize in small cytoplasmic
foci as well as large juxtanuclear aggregates that have been proposed to be aggresomes
(Friedman and Karen 2017). Initial studies showed that E4 11k increased Pat1b cytoplasmic foci
during Ad infections. It was also discovered that the E4 11k protein alone was efficient in
altering the localization of Pat1b (Friedman and Karen 2017).
Interestingly, cytoplasmic foci containing other P-body proteins, such as Ddx6 and Lsm1,
tend to decrease when aggresomes are present (Greer et al. 2011) while Pat1b foci tend to
increase during an Ad 5 infection. It has yet to be determined if E4 11k is required for this
relocalization of Pat1b, and if this relocalization is serotype-specific. Pat1b’s role during Ad
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infections are still unclear, but it is thought that Pat1b may act as a defense mechanism and
promote the decapping of viral mRNAs. Alternatively, the Ad virus may use Pat1b for its own
benefit by causing decapping of cellular mRNAs instead. Pat1b may also have functions related
to viral translation and replication. Pat1b has previously been discovered to affect viral RNA
translation in the brome mosaic virus (BMV) in yeast (Jungfleisch et al. 2015) as well as affect
translation and replication of the hepatitis C virus (Scheller et al. 2009).

Effect of E4 11k on the Synthesis of Late Viral Proteins
During the late stages of an adenovirus infection, cytoplasmic shuttling of most cellular
mRNA is inhibited. In return, viral mRNA is able to accumulate in the cytoplasm. Early proteins
E1B 55k, E4 34k, and E4 11k regulate nucleo-cytoplasmic shuttling of late viral mRNA to
promote viral replication (Leppard 1998). One late viral protein, L4 100k, promotes viral mRNA
translation by eliminating the cap-dependent translational pathways and suppressing cellular
mRNA activities. Multiple studies have demonstrated that mutant viruses with mutations in E1B
55k, E4 34k or E4 11k leads to reduced viral mRNA accumulation in the cytoplasm, which
decreases viral production (Leppard 1998). In a study conducted by Shepard and Ornelles
(2004), the E1B 55k-E4 ORF3 double mutant significantly reduced the accumulation of late viral
mRNA in the cytoplasm by 30-fold compared to the wild type infection. To determine whether
this decrease in viral mRNA reflected on the production of late viral protein synthesis, late viral
gene expression was measured in the double mutant, wild type, the E1B 55k-deleted mutant and
E4 ORF3-deleted mutant. The double mutant revealed that it was extremely defective in its
ability to shutdown host protein synthesis in order to produce late viral proteins. The E4 ORF3deleted mutant showed late viral protein expressions similar to that of the wild type while the
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E1B 55k-deleted mutant showed a significant decrease in late viral protein expression. However,
this decrease in late viral protein production was not as severe as the double mutant. These
results indicated that E4 ORF3 has functions involved in promoting late viral translation while
inhibiting transcription of early cellular proteins. We hypothesized that if the knockdown of
Ddx6 and Pat1b looked similar to the E1B 55k-deleted mutant then Ddx6 and Pat1b may have
roles in late viral production. Furthermore, if our hypothesis is true, then relocalization of Ddx6
to aggresomes and the increase in Pat1b foci may be mechanisms E4 11k uses to promote late
viral protein expression.

Research Goals

E4 11k functions to regulate host cell machinery to allow it to successfully replicate as
well as inhibit pathogenic cellular response pathways that may interfere with the virus’ life cycle.
It also stimulates late mRNA splicing. E4 11k is known to bind and relocalize p-body proteins,
which are involved in mRNA degradation and translational repression. Ddx6 is one p-body
protein that is relocalized by E4 11k to aggresomes (Greer et al. 2011). The reason for this
rearrangement is unknown. However, since E4 11k has a role in late gene expression, it is
possible that relocalizing Ddx6 prevents degradation of viral mRNA and enables the virus to
express late viral genes. Pat1b is another p-body protein that is possibly rearranged by E4 11k. It
has been demonstrated that the number of Pat1b foci increase during an Ad infection.

In order to determine if E4 11k is necessary for relocalization of Pat1b, I investigated
Pat1b and its localization prior to and post-Ad infection. The wild type virus, E1-replacement E4
ORF3-expressing virus, and an Ad virus with the E4 ORF1-3 genes deleted were used to
determine the effect E4 11k has on Pat1b. Once E4 11k was determined to be necessary and
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sufficient for Pat1b’s localization, different serotypes for the E4 ORF1-3 mutant were used to
determine if this relocalization was serotype-specific.

In order to determine the role of various p-body proteins being relocalized by E4 11k, we
knocked down Ddx6 to determine its role in the production of late viral proteins. The experiment
done by Shepard and Ornelles (2004) was modified to include the Ddx6 knockdowns. Similar to
Shepard and Ornelles, a mock, wild type, E1B 55k-E4 ORF3-deleted and 55k-deleted infection
was conducted. In addition to determine the role Ddx6 has on late viral protein production, Ddx6
was knocked down during a mock, wild-type, and 55k-deleted infection. We intended to knock
down Pat1b as well, but we had issues with finding an appropriate antibody to test the efficiency
of the knock down. An AHA metabolic labeling reagent and Click-iT reaction kit was used to
look at newly synthesized proteins. This will allow us to have a better understanding of the role
Ddx6 has late during an Ad infection.
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Materials and Methods
The materials and methods used in this study are as previously described by Friedman
and Karen (2017).
Cell Culture and Cell Line: Adenocarcinomic human alveolar basal epithelial cells (A549 cells)
were propagated in Dulbecco`s modified Eagle`s medium (DMEM) supplemented with 10% calf
bovine serum, 2mM glutamine, penicillin and streptomycin and seeded on collagen-coated
coverslips, and 60 mm plates and incubated at 37°C in 5% CO2.
Viruses and Infections: Wild type Ad 5, Ad 5 E1-replacement HA tagged E4-ORF3 and the E4ORFs 1-3-deleted (dl1013) viruses were used to determine the effect E4 11k had on
relocalization of Pat1b. The E1-replacement viruses were deleted of the E1A gene to prevent
expression of other early viral genes. E1 was then replaced with E4 ORF3 under the control of
the CMV promoter to only express the E4 ORF3 gene. To determine serotype-specificity, in
addition to Ad 5 HA-ORF3, Ad 9 HA-ORF3 and Ad 12 HA-ORF3 were also used as E1
replacement viruses. For analysis of newly synthesized proteins, E1B 55k-E4 ORF3-deleted
(dl1016), and 55k-deleted (dl110) viruses were also utilized. Cells were infected with 200 virus
particles per cell. For immunofluorescence assays, A549 cells were seeded on collagen-coated
coverslips in a 24-well plate and infected with each virus for 30 hours. For the Click-iT protein
analysis, A549 cells were seeded on 100mm plates, transfected for 36 hours, and then infected
for 36 hours.
Antibodies: Antibodies were prepared in 10% goat serum in PBS for immunofluorescence. The
antibodies that were used were anti-Ddx6 polyclonal antibody from Novus Biologicals, anti-HA
monoclonal antibody clone number (16B12), anti-Pat1b polyclonal antibody from Abnova, and
anti-DBP monoclonal antibody (B6-8). The secondary antibodies used were Alexa Fluor 594
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goat anti-mouse IgG, Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen). For western blotting
anti-Ddx6 polyclonal antibody (Novus Biologicals) was used and monoclonal gamma-tubulin
clone 4D11 (Invitrogen). The secondary antibodies used were Goat anti-rabbit 680 RD and Goat
anti-mouse 800 CW (IRDye).
Immunofluorescence: At 30 hours post-infection, cells were fixed and permeabilized using
100% methanol at -20°C for five minutes and then washed with 1X phosphate-buffered saline
(PBS). The cells were blocked using 10% goat serum and allowed to sit for an hour. The Pat1b
polyclonal antibody was diluted at 1:300, DBP was added at a 1:100 dilution, and anti-HA was
diluted 1:200 in 10% goat serum. The diluted antibodies were then incubated at room
temperature for 1 hour. Cells were washed with 1X PBS three times and placed on a rocker after
each wash. Secondary antibodies Alexa Fluor 594 and 488 were diluted 1:300 in 10% goat serum
and were added and incubated at room temperature for 45 minutes in the dark. The cells were
once again washed in 1X PBS three times. Afterwards, the nuclei were stained using 1 μl DAPI
for five minutes and washed with 1X PBS three times. After the final wash, fluoromount-G was
placed on slides and coverslips were mounted. The slides were viewed and images were obtained
using the Olympus FV3000 confocal microscope.
Transfection: A549 cells were transfected with Lipofectamine RNAiMax or Lipofectamine
3000 at 60% confluency on 60 mm plates. A549 cells were either mock transfected, or
transfected with siRNA against Ddx6 (ID: 121483) or siRNA against Pat1b (ID: 124106) for 36
hours. Some samples were then harvested and prepared for western blotting. For the Click-iT
analysis, cells were transfected for 36 hours then infected for 36 hours. Cells were then labeled
with the AHA metabolic labeling reagent for 4 hours. Cells were then harvested and lysed
according to the manufacturers protocol to be prepared for the Click-iT reaction.
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SDS-PAGE: A 40% Acrylamide gel was used. Acryl:Bisocryl, 1M pH 8.8 Tris, 10% SDS, 10%
APS, dH2O, and TEMED was used to make the resolving gel. The resolving gel set at room
temperature for about 15 minutes. Acryl:Bisocryl, 1M pH 6.8 Tris, 10% SDS, 10% APS, dH2O,
and TEMED were used for the stacking gel. 40µL of each sample with 4X loading buffer was
added to the wells. Gels were run at 120 volts for approximately 1 hour.
Transfer: Gels were transferred to a nitrocellulose membrane. The protein was
electrophoretically transferred (Bio-Rad) in Towbin buffer with SDS, which consisted of 25 mM
Tris, 192 mM glycine, 20% methanol, 0.01% SDS. The transfer was run at 100 mA for about an
hour.
Western Blot: Following transfer, the membrane was blocked in Odyssey blocking buffer in
TBS. The membrane was stained with primary antibodies gamma tubulin and Ddx6 in odyssey
buffer at 1:1000 Ddx6 and 1:5000 dilutions, respectively. The membrane was then washed with
TBS-Tween20 three times. Secondary antibodies, Alexafluor anti rabbit 680 and Alexafluor antimouse 800, were diluted at 1:5000 in 5% milk then incubated in the dark for 45 minutes. The
membrane was washed with TBS-Tween20 and then washed with TBS for 5 minutes each.
Images of the samples were then taken using the LICOR Odyssey machine. Images were imaged
at 600 nm and 700 nm.
Click-iT AHA labeling: After transfection and infection, the Click-iT AHA labeling was
performed according to the manufacturer's protocol. Cells were washed in 1X PBS warmed to
37°C then incubated in methionine-free media at 37°C for 1 hour. Five µL of 1000X AHA
(Invitrogen C10102) metabolic labeling reagent was added to the plates and incubated for 4
hours. AHA is a modified amino acid that contains an azido moiety that is delivered to cells and
incorporated in newly synthesized proteins. The Click-iT reaction is able to recognized azide
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labeled proteins and emits fluorescence at 532 nm allowing for visualization of the proteins.
Cells were then harvested and lysed using 1% SDS in 50 mM Tris-HCl at a pH of 8.0. Protein
concentration was determined using the BCA Protein Determination Kit. Up to 200µg of labeled
protein samples were used to perform the Click-iT reaction. After the Click-iT reaction, the
pellets were left to dry for 10 minutes and resolubilized in 2X sample buffer. Electrophoresis was
then performed. The gel was visualized using the LICOR Odyssey machine at 600 nm.
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Results
Pat1b is found in a nuclear pattern in mock-infected and Ad 5-infected cells.
Immunofluorescence studies were conducted to determine the localization pattern of
Pat1b during an Ad 5 infection. A549 cells were either mock infected, infected with wild type
Ad 5, the E1 replacement HA-ORF3 virus only expressing HA-ORF3, or the dl1013 virus (E4
ORF3 deleted virus) for 30 hours. We stained for Pat1b as well as the viral markers DBP and HA
to determine, which cells were infected. We did not observe any colocalization between Pat1b
and E4 11k. We expected to find Pat1b in cytoplasmic foci. However, we noticed large nuclear
aggregates in both mock and infected cells (Figure 3). The function of these aggregates is not
known and are most likely unrelated to the infections.

Figure 3. Localization of Pat1b during an Adenovirus Infection. A549 cells were mock-infected
(A), infected with wild-type virus (B), infected with the E1-replacement virus expressing only
the E4 ORF3 gene (C), or E4 ORF3-deleted virus (dl1013) (D). Cells were fixed at 30 hours
post-infection (hpi) and immunostained for DBP (B and D) or HA (C), and Pat1b. Nuclei were
stained with DAPI.
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E4 11k is necessary and sufficient for relocalization of Pat1b during an Ad 5 infection
When Pat1b foci were observed, we noticed that infection with an Ad 5 virus led to an
increase in Pat1b foci (Figure 4). Our data also revealed that there was a significant increase in
the number of Pat1b foci in the wild-type and the E4 ORF3 only virus when compared to the
mock (Figure 4). However, no significant difference was found between the mock and the E4
ORF3-deleted virus (Figure 4). These results show that E4 11k is necessary and sufficient in the
relocalization of Pat1b.

Figure 4. Quantification of Pat1b foci during different viral infections. A549 cells were infected
and stained as in Figure 3. The number of Pat1b foci were counted in 30 infected cells under
each condition. This was performed in duplicate and combined averages were plotted with error
bars representing standard error. Differences were determined by one-way ANOVA and Tukey's
test. * represents p<0.01, ** represents p<0.001, and *** represents p<0.0001.
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Rearrangement of Pat1b is serotype-specific
To determine if relocalization of Pat1b by E4 11k was serotype-specific, Pat1b foci were
counted in cells infected with E1-replacement viruses expressing HA-tagged Ad 5 E4 ORF3
(subgroup C), Ad 9 E4 ORF3 (Subgroup D) and Ad 12 E4 ORF3 (subgroup A) as seen in
Figures 5 and 6. Similar to Figure 4, the Ad 5 E4 ORF3-infected cells showed a significant
increase in Pat1b foci when compared to mock-infected cells. Pat1b foci in Ad 5 and Ad 12
infected cells showed a significant increase of 123% and 27%, respectively. An 18% increase
was observed between mock and Ad 9, which was not a significant difference according to the
Tukey’s post-hoc test. Since there was a significant difference between Ad 5, when compared to
mock, Ad 9, and Ad 12, and Ad 12 was only slightly significantly different from mock, this
suggests that relocalization of Pat1b is serotype-specific.
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Figure 5. Relocalization of Pat1b by E4 11k. A549 cells were mock-infected (A), infected with
Ad5 E4 ORF3 (B), infected with Ad9 E4 ORF3 (C) or infected with Ad12 E4 ORF3 (D). Cells
were fixed at 30 hours post-infection (hpi) and immunostained for HA and Pat1b. Nuclei were
stained with DAPI.

26

Figure 6. Serotype-specificity and E4 11k’s effect on Pat1b foci. A549 cells were infected and
stained as shown if Figure 3. Pat1b foci were counted in 30 mock-infected and Ad-infected cells.
The experiment was duplicated and the combined averages were graphed with error bars
representing standard error. A one-way ANOVA and Tukey’s test was used to indicated any
significant differences between any two groups. P-values <0.01 is indicated by *, ** represents
p-values <0.001 and p-value <0.0001 is indicated by ***.
To determine that knockdown of Ddx6 was successful, A549 cells were mock transfected
or transfected with siRNA against Ddx6. Gamma tubulin was used as a control and was seen in
both the mock and the Ddx6 knockdown. Expression of Ddx6 was reduced by 50%, which
confirmed that Ddx6 was successfully knockdown.
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Figure 7. Knockdown of Ddx6. A549 cells were transfected with siRNA against Ddx6 for 36
hours. Lipofectamine RNAi Max was used for the delivery of siRNA against Ddx6. Cells were
harvested and lysed. Lysed samples were then used for SDS-PAGE. A western blot was
conducted using antibodies against γ tubulin and Ddx6. The membrane was then imaged at 600
nm and 700 nm using the LICOR Odyssey Machine.

Newly synthesized proteins were observed on a gel to determine the function E4 11k and
Ddx6 have during late viral protein production. Although we are still optimizing to get bands that
are more distinguishable, the viral proteins, hexon, penton or L4 100k, does not appear to be
present in both the mock and mock siDdx6 lanes as expected. Similarly, E1B 55K-E4 ORF3deleted virus revealed that deletion of these two proteins inhibited synthesis of late viral proteins.
In the wild-type and 55k-deleted virus, hexon, penton and L4 100k are expressed. However, it
appears that knockdown of Ddx6 in wild-type infected cells prevented the production of late
viral protein, while late proteins can still be observed when Ddx6 is knocked down during a 55kdeleted infection. These results were unexpected and suggests that E4 11k is not relocalizing
Ddx6 to aggresomes as a mechanism for E4 11k to produce late viral proteins.
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Figure 8. E4 11k’s and Ddx6’s effect on synthesis of new proteins. A549 cells were transfected
for 36 hours followed by a 36-hour infection. Cells were labeled with AHA for 4 hours, then
harvested and lysed. The newly synthesized proteins were then labeled with the Click-iT
metabolic reagent. The samples then underwent SDS-PAGE gel electrophoresis. The gel was
then imaged at 600 nm using the LICOR Odyssey Machine.

Since we ran out of Lipofectamine RNAiMAX, we switched to Lipofectamine 3000.
Lipofectamine 3000 has also shown that it can be used for delivery of siRNA. A549 cells were
mock transfected of infected with siRNA against Ddx6. Gamma tubulin was used as a control.
As expected, gamma tubulin was observed in both mock and Ddx6 knockdown cells.
Transfection with siRNA against Ddx6 reduced expression of the protein by 97%.
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Figure 9. Knockdown of Ddx6. A549 cells were transfected with siRNA against Ddx6 for 36
hours. Lipofectamine 3000 was used for the delivery of siRNA against Ddx6. Cells were
harvested and lysed. Lysed samples were then used for gel electrophoresis. A western blot was
conducted using antibodies against γ tubulin and Ddx6. The membrane was then imaged at 600
nm and 700 nm using the LICOR Odyssey machine.
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Discussion
Eukaryotic cells respond to viral infections and other external and internal stress
conditions by placing the host cell under cellular arrest and preventing the translation of both
cellular and viral protein translation. These translationally repressed mRNAs have been shown to
localize in cytoplasmic RNP granules, such as p-bodies. The majority of p-body proteins are
involved in mRNA repression or decay, and their size and number vary depending on the
physiological conditions of the cell (Teixeira et al. 2005). Numerous studies have demonstrated
multiple patterns of p-body disruption in a variety of viral infections. Specific viruses have been
shown to rearrange specific p-body proteins. In our study, we observed that Pat1b foci increased
during an Ad 5 infection, but this increase was only observed when E4 11k was present. This
increase in Pat1b foci was found to be specific to Ad 5 (Figure 6).
It is possible that the increase in Pat1b foci may be due to dispersal of the protein by E4
11k. Alternatively, this could be due to the structural integrity of the p-bodies becoming
compromised from Ddx6 rearrangement. As Ddx6 and Pat1b both have key scaffolding roles in
the formation of p-bodies, removal of one may result in the dispersal of the other. The significant
increase could also be a result of the protein becoming overexpressed; however, we do not have
evidence that overexpression of Pat1b is occurring at this time. Ad infections also resulted in
finer Pat1b foci among all observed serotypes. Finer foci were also observed in an E4 ORF3deleted mutant suggesting that E4 11k is not responsible for the reduction in p-body size. The
observed finer foci in Ad infected cells could be caused by cellular stress.
Other viruses have been shown to disrupt p-bodies during their infections. West Nile
virus (WNV) has been shown to diminish p-bodies during infection. Interestingly, the protein
expression level of these p-body proteins (Ddx3, Ddx6 Xrn1, Lsm1, Gw182 and Dcp1) remained
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the same while their mRNA level increased (Chahar et al. 2012) Gw182, Lsm1, Ddx3, Ddx6 and
Xrn1 are recruited to viral replication sites and colocalize with the viral protein NS-3.
Knockdown of these proteins decrease WNV replication. Dcp1a and Edc3 on the contrary are
not recruited viral replication centers. An opposite pattern is seen in HIV infections. Depletion of
p-body proteins such as Ddx6, Lsm1 and Xrn1 enhances HIV replication. Depletion of Ddx6
also releases translational repression and enhances production of viral proteins (Nathans et al.
2009).
During adenoviral infection, E4 11k disrupts p-bodies and has shown that it colocalizes
with Ddx6 in juxtanuclear aggresomes. When aggresomes are present, p-bodies containing Ddx6
are diminished (Greer et al 2011). To determine whether Ddx6 has a function in synthesis of
viral proteins, Ddx6 was knocked down. Although we cannot conclude the role Ddx6 has during
late times of infection, our data appears to indicate that Ddx6 does not affect the synthesis of
viral proteins in Ad infections (Figure 8). This suggests that there could be another function E4
11k uses that involves rearranging Ddx6 from p-bodies to aggresomes. In order to determine the
impact that other p-body proteins in addition to Ddx6 have during an adenoviral infection, it
would be interesting to examine the effect that knockdown of p-body proteins such as Lsm1,
Xrn1, Dcp1a, Edc3 and Pat1b have on adenoviral infections.
In a continuation of previous research regarding the localization of Pat1b during an
adenoviral infection (Friedman and Karen 2018), our data confirm that E4 11k is sufficient in
increasing the number of cytoplasmic foci containing Pat1b during an Ad 5 infection. In contrast,
cells containing E4 11k-induced aggresomes, revealed a decrease in cytoplasmic p-bodies
containing Ddx6 (Greer et al. 2011). The reason for this contrast is unknown. However; the
increase in Pat1b foci may be a consequence of the decrease in Ddx6 found in p-bodies.
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Relocalization of Ddx6 to E4-11k-induced aggresomes, disrupts, and as a result of this
disruption, Pat1b may become dispersed into smaller foci.
Previously it has been shown that the presence of E4 11k is sufficient in increasing Pat1b
foci. To determine if it required for relocalization of Pat1b, we added an E4 ORF3-deleted
mutant. We observed that there was no significant difference between mock cells and E4 ORF3deleted infected cells. This suggests that Pat1b is necessary for the relocalization of Pat1b. We
also aimed to determine whether this rearrangement of Pat1b was serotype-specific. We initially
planned to count and compare Pat1b foci in cells infected with Ad 3 E4 ORF3 (subgroup B), Ad
4 E4 ORF3 (subgroup E), Ad 5 E4 ORF3 (subgroup C), Ad 9 E4 ORF3 (subgroup D), and Ad 12
E4 ORF3 (subgroup A). However, we were not able to infect with Ad 3 and Ad 4. According to
our data, we cannot officially conclude that this relocalization is serotype-specific, but it was
interesting to see that there was a significant increase in the observed Pat1b foci in Ad 5-infected
cells compared to mock, Ad 9 and Ad 12, which indicates that relocalization of Pat1b is specific
to Ad 5. The reason for such an increase has not been determined. There was also an observed
increase in Pat1b foci in Ad 5 and Ad 12 infected cells compared to mock This may suggest that
E4-11k disrupts Pat1b in p-bodies in other Ad serotypes to some extent. A similar pattern was
observed with the localization of Ddx6 during adenoviral infections with Ad serotypes 3, 4, 5, 9
and 12. Ad 5 was the only serotype that could relocalize Ddx6 to aggressomes, but all serotypes
disrupted p-bodies due to the presence of E4 11k and relocalized Ddx6 to different distinct
cytoplasmic structures (Greer et al. 2011). The reason for the observed increase in Pat1b foci is
unknown; however, this increase could be a response to cellular stress caused by over expression
of E4-11k. Since p-bodies are sites for mRNA degradation, E4-11k’s ability to relocalize Ddx6
and Pat1b may promote the stimulation of late viral protein accumulation in the cytoplasm. In
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order to determine the role Ddx6, Pat1b and E4 11k have on late viral protein production, Ddx6
was knocked down in an E1B 55k-mutant background. The Click-iT reaction was used to
determine the presence of newly synthesized proteins. These preliminary results suggest that
Ddx6 does not play a role in the production of late viral proteins, however, there are some
controls of the experiment that do not appear to make sense so it will need to be repeated to
make any solid conclusions. If confirmed, this would indicate that relocalization of Ddx6 to
aggresomes is not a mechanism E4 11k uses to stimulate late viral protein production,
In addition to confirming the role E4 11k and Ddx6 have on late viral protein production,
Pat1b knockdowns will be added. It is also important to get an accurate representation of Pat1b
foci across all known subgroups to shed light on whether the rearrangement of Pat1b is truly
serotype-specific. The sample size will be increased and Pat1b foci from serotypes Ad 3, Ad 4,
Ad 5, Ad 9 and Ad 12 will be counted.
While our data suggest that E4 11k increase the number of Pat1b foci in Ad 5 and Ad 12
infected cells, it’s important to note that we encountered some difficulties with counting Pat1b
foci. The size of Pat1b foci varied in both the mock and Ad-infected cells. The intensity of the
fluorescence also differed from foci within the same cell. In an attempt to avoid any
discrepancies while counting Pat1b foci, we experimented with the CellSens counting software,
but were unable to successfully find a way to use the software for our purposes. In the future,
software that can measure the intensity of fluorescence and foci size will be sought, to prevent
any bias in the results.
Currently, there are not many studies that demonstrate the effect DNA viruses have on
the structural integrity of p-bodies or p-body proteins stability. P-bodies have the ability to
degrade viral mRNAs; however, p-bodies may also give rise to an opportunity for viruses to
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regulate cellular gene expression. Altogether, our results demonstrated that E4 11k plays a
crucial role in relocalizing Pat1b to more numerous foci. E4 11k is known to modulate host gene
expression. Since Pat1b is a scaffolding protein and is essential for p-body assembly,
relocalization of Pat1b by E4 11k may also lead to the dissociation of other proteins from pbodies. This may explain the reason for the observed smaller Pat1b foci during an Ad infection.
It is possible that disruption of p-bodies by E4 11k is a mechanism the virus uses to allow for
accumulation of viral mRNAs in the cytoplasm. Although the roles p-bodies have during a viral
infection are still not well understood, our results provide insight on how p-bodies are disrupted
during a viral infection.
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